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Abstract 
 
The mechanisms by which obesity increases cancer risk are unclear, but some lines of 
evidence suggest that gut microbial communities (GMC) may contribute to chronic 
inflammation in obese individuals through raised systemic levels of lipopolysaccharides 
(LPS). We evaluated associations of the GMC in stool with plasma LPS-binding protein 
(LBP, a measure of LPS) and C-reactive protein (CRP) concentrations in 110 
premenopausal women in the United States. Diet was assessed using 3-day food records 
and GMCs were evaluated using pyrosequencing of the 16S rRNA gene. OTUs were 
identified at 97% sequence similarity. Taxonomic classification and functional genes 
were imputed from 16S rRNA genes, and alpha and beta diversity were assessed using 
the Shannon index and MRPP, respectively. Multivariable linear regression analysis 
was used to assess the relation between LBP, specific bacterial genera identified with 
Indicator Species Analysis, and CRP. Dietary fat intake, particularly saturated fat, and 
CRP were positively associated with increased LBP. GMC beta diversity, but not alpha 
diversity, was statistically significantly different between groups using unweighted 
Unifrac. Several taxa, particularly those in the Clostridia class were more prevalent in 
women with low LBP, while Bacteroides were more prevalent in those with high LBP. 
Genes associated with gram negative cell wall material synthesis were also associated 
with LBP and CRP. In contrast, Phascolarctobacterium was associated with lower 
concentrations of LBP and CRP.  
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We found distinct differences between tertiles of LBP regarding the diversity and 
composition of the microbiome, as well as differences in functional genes that 
potentially activate LBP.  
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Introduction: 
 
Current evidence suggests a possible role of gut microbiota in the pathogenesis 
of obesity and its concomitant diseases, including several cancers [1–3]. Obesity, 
especially adiposity, is associated with systemic microinflammation (i.e. chronic low-
grade inflammation) [1]. Furthermore, adipocytes and macrophages infiltrating visceral 
adipose tissue in obese individuals are a source of circulating pro-inflammatory 
cytokines, such as TNF-α, IL-1, and IL-6 [1,4,5]. More recently, research has suggested 
that an alteration in gut microbial communities (GMC) escalates systemic micro-
inflammation, at least in obese individuals [6]. 
Lipopolysaccharide (LPS), a cell wall component of gram-negative bacteria, has 
been identified as an underlying factor of obesity-driven low-grade inflammation [7]. 
Lipopolysaccharide-binding protein (LBP), a protein that binds to LPS and transfers 
LPS monomers to CD14, is driven by circulating concentrations of LPS [8]. Exposure 
to LPS induces an increase of LBP production in the liver within 15 to 30 min [9], with 
a maximum serum level occurring after 24-48 hours [10].  The LPS-LBP-CD14-MD2 
complex elicits a pro-inflammatory response by Toll-like receptor 4 (TLR4) mediated 
NF-κB activation [11], and, as such, circulating levels of LBP have been found to be 
associated with systemic inflammation [12]. C-reactive  protein (CRP), a biomarker of 
inflammation, is associated with increased LPS [13].   
Recent studies have shown that LBP, a marker of LPS exposure, is associated 
with high-fat diets and obesity [7,14–17]; however, relatively few studies have 
examined whether LBP levels vary by GMC distribution and adiposity. Previous reports 
have shown a strong association between concentrations of circulating LBP, obesity-
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associated metabolic disturbances, and increased inflammatory signaling [7,18,19]. 
Moreover, LPS-driven inflammation may play a role in the pathogenesis of several 
adverse outcomes, including inflammatory bowel disease [20–22], and cancer [23,24]. 
Nonetheless, the interplay between obesity, GMC, LBP, and inflammation has yet to be 
elucidated. The goal of the proposed study was to examine whether GMC varies by 
LBP concentrations, whether there are specific genera associated with varying levels of 
LBP, and whether these genera are associated with inflammation, as measured by CRP 
concentrations. 
Methods: 
Study Participants 
Participants were from the Equol, Breast and Bone (EBB) study, which was designed 
to evaluate the relationship between bacterial metabolic phenotypes, diet and other exposures, 
and biomarkers of sex steroid hormone status, has been previously described [25]. Briefly, 
participants in the EBB study were recruited from the Group Health Cooperative 
(GHC), a large mixed-model health care system in Washington State. Women were 
eligible if they were premenopausal, aged 40 to 45 years, and had received a screening 
mammogram at GHC prior to recruitment. Women were ineligible to participate if they 
were allergic to soy beans or soy protein; had been diagnosed with Crohn’s disease or 
ulcerative colitis or had any part of their colon removed; had been diagnosed with breast 
cancer; were pregnant or planning to become pregnant; had a hysterectomy or any part 
of their ovaries removed; were perimenopausal (skipped ≥1 periods in the previous 12 
months, or had irregular bleeding patterns); were currently using hormone therapy or 
oral contraceptive, had used them for ≥1 month in the past 12 months, or had used them 
in the 6 months before their screening mammogram; were currently taking antibiotics or 
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had taken them for ≥1 month in the previous 12 months; or had ever taken tamoxifen or 
were currently taking raloxifene, bisphosphonates, or oral steroids. 
After obtaining informed consent, EBB participants were mailed a health and 
demographics questionnaire and a physical activity questionnaire, to be completed prior 
to their clinic visit. At the clinic visit, weight and height were measured as well as body 
fat distribution (adiposity %), which was assessed using dual energy X-ray 
absorptiometry (DXA; Hologic Delphi, Hologic Inc.). Participants also provided a 12 
hour fasting blood sample at the clinic visit.  All samples were processed within 1 hour 
of collection, aliquoted into 1.8-ml tubes, and stored at –70°C. Date, time of collection, 
and time since last meal were recorded. Stool sample collection was optional. Study 
participants were asked to place a sample in RNAlater and samples were stored at −80 
°C when received by the lab, as previously described [26,27]. Additionally, all 
participants were asked to complete a 3-day food record (3DFR) within two weeks of 
the clinic visit.  
A total of 1,407 women were identified as potential participants from the Group 
Health Breast Cancer Screening Program. Of these women, 367 (26%) were found to be 
ineligible, 691 (49%) refused participation, and 146 (10%) were not able to be 
interviewed or scheduled for a clinic visit. Of the 203 EBB study participants, 110 
completed a health questionnaire, provided stool and blood samples, and had body fat % 
measured from a DXA scan.  
Biological Specimens  
LBP concentrations were measured in plasma using a commercial ELISA kit (Cell 
Sciences Inc): samples were diluted 1:1000 and the assay was conducted per kit 
protocol with a standard curve of 5-50 ng/mL. Serum CRP was measured using CRP 
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Ultra Wide Range reagent (Genzyme Diagnostics) on a Roche Cobas Mira chemistry 
analyzer and read at 570 nm. Samples were run in duplicate, and the mean duplicate 
intra-assay coefficients of variation (CV) were: 4.7% for LBP, and 4.1% for CRP.  A 
blinded and pooled plasma sample was included in each batch to track plate-to-plate 
variation. The inter-batch CV was 12.5% for LBP and the assay was conducted on once-
thawed samples.  
Microbiome bioinformatics analysis 
 DNA extraction and 16S rRNA gene sequencing methods used on EBB samples 
have been previously described [26]. Briefly, DNA was extracted from stool that had 
been stored in RNAlater. The V1-V3 region of the 16S rRNA gene was amplified and 
sequenced using 454 pyrosequencing primers 27f and 519r.  Sequences were compiled 
and processed using QIIME (v.1.8)[28]. Sequences were removed if they were < 200 bp 
or > 700 bp, had homopolymers >6 bp, more than one mismatch to the forward primer, 
more than one mismatch to the barcode, or more than six ambiguous bases. Sequences 
were truncated with a quality score sliding window of size 50 bp using a threshold of 
25. Initial operational taxonomic unit (OTU) generation, wherein microorganisms were 
grouped by DNA sequence similarity of a specific taxonomic marker gene, was done 
using UCLUST in QIIME at 97% similarity [29]. The OTU table was filtered using the 
QIIME script filter_otus_from_otu_table.py with --min_count_fraction set to 0.00005 as 
recommended in Navas-Molina et al [30]. An additional filtering step set entries in the 
OTU table to zero if the number of observations was less than 10 per-sample, per-OTU.  
Additional OTU entries were filtered out if they were detected as chimeras using 
QIIME’s identify_chimeric_seqs.py script with method blast_fragments. Sequences 
were aligned to the Silva 16S rRNA gene reference alignment using the NAST 
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algorithm[31]. Sequences that did not align to the appropriate 16S rRNA gene region 
were removed. The sequences were classified using MOTHUR’s naive Bayesian 
Classifier trained against the SILVA database (release 111) clustered at the 97% 
similarity level [32]. Classified sequences were assigned to phylum and genus-level 
phylotypes to characterize the community structure. Rarefaction was performed as 
uneven sampling depth biases alpha (within-person) and beta (between-person) 
diversity estimates.  Two participants were dropped after OTUs were rarefied to 1,578 
sequences per sample. 
Analysis of GMC functional profiles 
Profiling phylogenetic marker genes, such as the 16S rRNA gene (as outlined 
above), is needed to understand the distribution of microbial communities, but does not 
provide direct evidence of a GMC’s functional capabilities. We used PICRUSt[33] to 
predict the metagenomic contribution of genes whose products may influence LBP 
activation namely, LPS biosynthesis and lipoteichoic acid (LTA) biosynthesis (a marker 
of gram-positive bacteria) in our study population. PICRUSt has been utilized 
previously to describe differences in potential function within human samples and 
positively corresponds to actual metagenomic and metabolic comparisons [33].  
Statistical Analysis 
 Differences in baseline characteristics (age, education, dietary variables, 
physical activity, body fat, CRP) were calculated using ANOVA. Diversity of the 
microbial community within an individual (alpha diversity), was calculated from OTUs 
(at 3% divergence) using the Shannon Index. Differences in phylum, functional genes, 
and Shannon index values between tertiles of LBP were calculated using ANOVA. Beta 
diversity estimates, which represent the similarity (or difference) in organismal 
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composition between subjects were based on weighted and unweighted UniFrac 
distance matrices [34]. Unweighted UniFrac estimates the presence or absence of OTUs 
between individuals while weighted UniFrac is a quantitative measure based on relative 
abundance of OTUs between individuals. Given that these metrics may be viewed as 
complementary approaches that explore different aspects of how communities vary 
between individuals, both weighted and unweighted Unifrac matrices were used in the 
analysis. 
 Multiple response permutation procedure (MRPP) [35] was conducted to test 
whether the GMC composition differed between tertiles of LBP. MRPP was performed 
with 1,000 permutations on weighted and unweighted UniFrac distance matrices. 
Differences in the GMC by tertiles of LBP concentration were visualized by NMS 
ordination plots.  
Indicator species analysis (ISA) [36] complemented MRPP by assigning significant 
indicator values to bacteria taxa (at the genera level) that were indicative of community 
structure separation between LBP tertiles. To adjust for differences in per-subject 
sampling frequency, P-values were averaged over 1,000 bootstrap iterations with even 
per-subject sampling frequency. Bootstrapped P-values were adjusted for FDR using the 
Benjamini and Hochberg (B-H) method [37] based on the total number of taxa after 
excluding those that represented < 1% average relative abundance. 
 The Kruskal Wallis (K-W) tests were used to assess whether phyla and 
abundance of functional genes (lipopolysaccharide biosynthesis and LTA synthesis) 
differed by tertile of LBP.  
To test the association between LBP and inflammation, a binary CRP value was 
created to represent CRP concentrations >1 mg/L vs. ≤1 mg/L. The cutoff value of 1 
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mg/L was based on clinical guidelines [38] and previous studies [39]. Unconditional 
logistic regression was used to compute odds ratios (ORs) and 95% confidence intervals 
(CIs) for the relationship between LBP, the exposure variable, and CRP, the outcome 
variable. Additional adjustment for a priori confounders (smoking status and age) was 
performed in the multivariable model.  
Additionally, regression models adjusting for smoking status and age were run to 
test the association between taxa identified in the ISA analysis (categorized into tertiles) 
and circulating CRP (dichotomized as (>1 mg/L and ≤1 mg/L). Rare taxa, those that 
were present in less than half the population, were not included in the analysis. 
 All reported P-values are two-sided, and a P-value < 0.05 was considered 
statistically significant. All analyses were carried out using STATA 14 (StataCorp, 
College Station, TX), QIIME [40], R version 3.3.1 (http://www.r-project.org), 
vegan[41], ggplot2[42], and labdsv [43].   
Results: 
Characteristics of the study population and macronutrient intakes by tertiles of LBP 
concentrations are shown in Table 1. No substantial differences in ethnicity, education, 
smoking history, age, dietary fiber intake were observed across tertiles. CRP was 
statistically significantly different between tertiles of LBP (P = 0.002), with higher 
tertiles corresponding to higher CRP values. Compared to those in the lowest tertile, 
those in the highest tertile of LBP had a higher total fat intake, saturated fat intake, and 
% body fat, although these differences were not statistically significant. 
Bacteria were distributed across phyla: Actinobacteria (0.2%), Bacteroidetes 
(30.4%), Cyanobacteria (0.03%), Firmicutes (67.7%), Lentispharae (0.06%), 
Proteobacteria (1.2%), and Tenericutes (0.4%), and Verrucomicrobia (0.03%) (Table 2). 
Firmicutes decreased while Bacteroidetes increased with LBP concentration although 
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these differences were not statistically significant. Additionally, the relative abundance 
of Actinobacteria was statistically significantly different between the three LBP groups 
(P=0.03). Moreover, imputed genes for LPS biosynthesis were statistically significantly 
different by tertiles of LBP (Tertile 1: 254.8, Tertile 2: 287.6, Tertile 3: 339; P 
<0.0001). However, genes in the LTA biosynthesis pathway were not statistically 
significantly different between groups.  
The bacterial alpha diversity measured by the Shannon Index was not significantly 
different between tertiles of plasma LBP (Tertile 1: 4.58; Tertile 2: 4.46; Tertile 3: 4.66, 
ANOVA, F=0.3356, n=110, P=0.71; Table 2). Beta diversity was significantly different 
between tertiles of LBP using unweighted Unifrac (MRPP; A=0.005, P=0.027, 1,000 
permutations), but no difference between tertiles of LBP was observed using weighted 
Unifrac (MRPP; A=0.0002919, P=0.20; 1,000 permutations; figure not included).  
Using Indicator Species Analysis (ISA), we found that 16 bacterial OTUs were 
associated with LBP. Of these, 14 phylotypes were “indicators” of low levels of LBP 
concentrations, and two were indicators for the highest tertile of LBP (Table 3).  
Uncultured Christensenellaceae and unclassified Ruminococcaceae showed the highest 
indicator values for low LBP, while Bacteroides was the strongest indicator for high 
LBP.   
In the unadjusted model, LBP was statistically significantly associated with CRP >1 
mg/L (Ptrend = 0.02) and the OR among those in the third tertile for LBP (22.2 – 94.7 
µg/mL) was statistically significantly higher than that in the lowest tertile (OR = 2.98; 
95% CI = 1.14-7.80). However, in the adjusted model, there was no observed 
association among those in the highest (third) LBP quartile (OR = 2.09; 95% CI = 0.76-
5.80) and the test for trend was not statistically significant (Ptrend = 0.15).  In both the 
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crude and the adjusted model, the association between Bacteroides and CRP > 1 mg/L 
increased across tertiles of Bacteroides, with a non-statistically significant trend 
observed across the three groups (Ptrend = 0.08).  
Compared to no Phascolarctobacterium present (first tertile), high levels of 
Phascolarctobacterium (third tertile) were statistically significantly associated with 
CRP ≤ 1 mg/L (OR = 0.30, 95% CI: 0.11–0.81); with a monotonic trend observed 
across the three groups (Ptrend = 0.02) in the adjusted model (Table 4).  For the 
remaining genera, overall bacteria levels were not statistically significantly associated 
with CRP > 1 mg/L in either the crude or the multivariable adjusted models.  
Discussion: 
 
Microbial mechanisms have been linked to inflammation that may be associated 
with increased risk for cancer and other chronic diseases. One such pathway is through 
dietary-related shifts in the gut microbiome linked to activation of the innate immune 
response. In this cross-sectional study, we found distinct differences in the diversity, 
and composition of the stool microbiome and some potential functional pathways for 
synthesis of cell wall material in gram-negative and gram-positive bacteria between 
tertiles of LBP. Furthermore, study results showed that differences in bacterial genera 
that potentially activate LBP were associated with increased inflammation.  
Diets, particularly high-fat diets, may contribute to the microbiome-inflammation 
relationship [44,45]. In this study of premenopausal women, we found a non-statistically 
significant positive association between increasing tertiles of circulating LBP and dietary 
fat intake. Mechanisms associated with a higher systemic LPS load and increased LBP 
response include 1) increased translocation of LPS via chylomicron uptake and/or 2) 
increased intestinal permeability  associated with diet [6,46,47]. A cross-sectional study of 
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healthy men aged 45-64 years, observed that fat intake was significantly associated with 
increased endotoxin load [48] while other studies have found that high fat/high 
carbohydrate foods increase LPS load, thus suggesting that diet may influence circulating 
levels of LPS concentrations [7,49,50].  
Changes in diet leading to changes in inflammation have been associated with shifts 
in microbial community structure [51,52]. Our results extend these findings by showing 
that the overall composition and functional genes associated with gram negative cell 
wall synthesis were associated with higher levels of LBP. We found that the overall gut 
microbiome composition in individuals with higher circulating concentrations of LBP 
was different from those with lower levels using unweighted Unifrac, but these findings 
were not observed using weighted Unifrac. The discrepancy in results suggest that there 
may be differences in rarer taxa between tertiles of LBP, as unweighted Unifrac is 
sensitive to rarer taxa while weighted Unifrac is less influenced by these taxa [53].  
Further analysis revealed that several taxa, particularly those found in the gram-
positive Clostridia class, may be more prevalent with low levels of LBP while 
Bacteroides may be more prevalent with high levels of LBP. In the lowest tertile, the 
highest indicator value belonged to the gram-positive Christensenellaceae genus, which 
has been found to be more abundant in lean individuals[54]. Animal models have also 
shown that transplantation of Christensenellaceae into germ-free mice protected against 
weight gain[55]. Christensenellaceae, one of the most heritable members of the 
microbiome, has also been inversely associated with obesity in other animal and human 
studies [56,57] Thus, findings suggest that the association between LBP and obesity, 
may, in part, be driven by the genera (or lack thereof) associated with higher LBP 
concentrations. Alternatively, the highest indicator value in the highest tertile of LBP 
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was Bacteroides, a gram-negative genus which has been associated with both obesity 
and inflammatory bowel disease in previous studies [58,59]. Taken together, these 
findings point to an association between increased levels of bacteria associated with 
obesity and inflammation, and increased levels of circulating LBP, supporting the 
hypothesis that changes in dietary patterns may lead to shifts in the gut microbiome, 
subsequently leading to obesity and inflammation.  
In addition to differences in genera present by LBP, we also observed functional 
differences in GMC that may be associated with LBP concentrations. LPS biosynthesis, 
based on pathway genes identified in KEGG, was statistically significantly different by 
tertiles of LBP. These findings support the hypothesis that the GMC associated with 
chronic low-grade inflammation may, in part, be driven by gene differences which can 
be detected as differences circulating LBP. Alternatively, we did not observe any 
differences in LTA synthesis genes across LBP tertiles. While previous studies have 
shown that activation of cellular responses by LTA, a cell wall component of gram-
positive bacteria, is enhanced by LBP [60,61], no previous studies have examined the 
association between LTA genes and circulating LBP levels; current study results 
suggest that the functional potential of genes related LTA synthesis is not associated 
with those responsible for LPS synthesis.  
The LPS-LBP-CD14-MD2 complex elicits a pro-inflammatory response by TLR4-
mediated NF-κB activation [11], and, as such, circulating levels of LBP have been 
found to be associated with systemic inflammation [12]. CRP, a biomarker of 
inflammation, has also been shown to be associated with increased LPS [13]. Consistent 
with previous studies which have observed an association between LBP and 
inflammation [14,62], our study showed that LBP concentrations were associated with 
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inflammation (as measured by CRP), but only adding covariates to the model. Failure to 
observe an association in the multivariable model may be due to mediation effects of 
LBP on the association between the covariates and CRP, confounding, or the small 
sample size.  
Phascolarctobacterium, a gram-positive bacterium in the Negativicutes class, was 
associated with both low LBP concentrations and with low CRP concentrations in our 
study.  Additionally, we found that LBP was associated with a higher dietary fat intake, 
but not with dietary fiber or carbohydrate intakes.  Interestingly, Phascolarctobacterium 
ferments carbohydrates to the short-chain fatty acid propionate [63], a bacterial 
metabolite that has anti-lipogenic, cholesterol-lowering, anti-inflammatory, and anti-
carcinogenic properties [64,65]. Propionate has been associated with increased satiety, 
which may be associated with reduced inflammation [66]. These findings complement 
prior studies which have shown that Phascolarctobacterium is associated with 
cruciferous vegetable intake [67] and is significantly reduced in individuals with 
inflammatory bowel disease [68,69]. Thus, findings from the current study suggest that 
LBP is associated with CRP, perhaps through a decrease in gram-positive bacteria that 
may be associated with reduced inflammation.  
Strengths of the study include use of a well-described population of pre-menopausal 
women and stringent exclusion criteria, which removed factors that could potentially 
influence GMC (e.g., antibiotic and other medication use). Additionally, careful 
assessment of diet using a 3DFR, rather than a FFQ, reduced the potential for 
measurement error due to poor recall.  
  Limitations of our study, beyond the sample size, are the cross-sectional design, 
and lack of metagenomics data to assess functional genes. The study design cannot 
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measure temporal relationships, and as such, prospective studies are needed to assess 
whether changes in GMC lead to changes in inflammation. The annotations used in 
KEGG suggest the functional potential of the community, but the presence of these 
genes/functions does not mean that they are biologically active (i.e., they may not be 
transcribed). However, in the current study, an increase in LPS biosynthesis was 
observed in conjunction with an increase in the gram-negative genera Bacteroides, 
suggesting that the annotations using KEGG captured the functional gene presence. 
Forward primer selection may also have influenced results, as previous study has shown 
that Actinobacteria and Bifidobacterium abundances were underestimated when using 
the 27f primer [70].  
Additionally, timing between diet and stool collection may have influenced results 
as 3DFR were collected within two weeks of stool sample collection. While ideally diet 
and stool samples would be collected at the same time, as changes in dietary patterns 
can change microbial communities in less than a week [71], a study by Wu et al. found 
that short term dietary changes were modest and did not impact enterotype partitioning 
established through long-term dietary patterns [72].  Furthermore, while the study 
presents novel findings based on ISA, independent replication is required as these 
associations were not established a priori. Results may have been due to chance, given 
that many taxa were examined, although p-values were corrected for multiple testing.  
Similarly, findings related to ISA genera and CRP may have been due to chance, given 
the exploratory nature of the analysis and subsequent number of regression models run. 
Furthermore, given that the study was conducted among pre-menopausal women, results 
may not be generalizable to the overall population.  
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 The current study found that the GMC differs in relation to plasma LBP 
concentrations and the association between LBP and CRP may be due to the presence of 
certain LPS-producing bacteria that increase LBP concentrations. Our findings point to 
an association between increased levels of bacteria associated with obesity and 
inflammation, and increased levels of circulating LBP. To our knowledge, this is the 
first study to examine LBP in relation to CRP and GMC, validation of our findings in 
larger, prospective studies is needed to establish temporal relationships and whether 
dietary patterns leads to shifts in the gut microbiome, subsequently leading to obesity 
and inflammation.
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